Gonadal involvment in leprosy — study of gynaecomastia, testicular and epididymal involvement and therapeutic efficacy of indigenous drugs
Autor(a) principal: | |
---|---|
Data de Publicação: | 1984 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Hansenologia Internationalis (Online) |
Texto Completo: | https://periodicos.saude.sp.gov.br/hansenologia/article/view/35571 |
Resumo: | Sixty male patients of leprosy (mean age = 27.2+5.04 years) selected at random, were studied for gonadal involvement and therapeutic efficacy of two indigenous drugs. Of these 34 were married, with the mean duration of illness 4.17+3.27 years. Only those with lepromatous and dimorphous leprosy developed testicular and epididymal changes. Testicular pain and/or swelling (lepromatous =62.5%, dimorphous 30%) was the commonest presenting feature. Altered sexual function was observed in 34 (56.6%) cases, while 11 patients revealed altered sexual hair pattern and nine gynaeco-mastia. Reduced testicular size associated with soft feel was present in 25% of cases with no testicular sensation in 8 (13.3%) and impaired testicular sensation in 9 (15%) patients. Spermogram revealed azoospermia in 19 (35%) and oligospermia in 16 (26.6%) patients. Histopathological findings of testicle biopsy revealed evidence of leprous pathology irrespective of testicular size, semen picture and clinical manifestations. Histopatho-logical changes had shown marked variation and so did not enable categorising them into vascular, interstitial and obliterative phases. These changes were believed to be due to the altered gonadal state in leprosy. The therapeutic efficacy of the indigenous preparations, Speman and Tentex forte (Himalaya) was evaluated subjectively as well as objectively in 34 patients. 823% of cases showed subjective improvement while objective improvement in spermogram was noted in 87.5% cases with oligospermia. The drugs have no side effect and were well tolerated. |
id |
ILSL-1_c4e1a6d4e7400f28cd22e65cd63b1cf6 |
---|---|
oai_identifier_str |
oai:ojs.periodicos.saude.sp.gov.br:article/35571 |
network_acronym_str |
ILSL-1 |
network_name_str |
Hansenologia Internationalis (Online) |
repository_id_str |
|
spelling |
Gonadal involvment in leprosy — study of gynaecomastia, testicular and epididymal involvement and therapeutic efficacy of indigenous drugsGônadasGinecomastiaTestículoEpidídimosHanseníasePreparação nativaGonadsGynaecomastiaTesticle, EpididymesHanseniasisLeprosyIndigenous drugsSixty male patients of leprosy (mean age = 27.2+5.04 years) selected at random, were studied for gonadal involvement and therapeutic efficacy of two indigenous drugs. Of these 34 were married, with the mean duration of illness 4.17+3.27 years. Only those with lepromatous and dimorphous leprosy developed testicular and epididymal changes. Testicular pain and/or swelling (lepromatous =62.5%, dimorphous 30%) was the commonest presenting feature. Altered sexual function was observed in 34 (56.6%) cases, while 11 patients revealed altered sexual hair pattern and nine gynaeco-mastia. Reduced testicular size associated with soft feel was present in 25% of cases with no testicular sensation in 8 (13.3%) and impaired testicular sensation in 9 (15%) patients. Spermogram revealed azoospermia in 19 (35%) and oligospermia in 16 (26.6%) patients. Histopathological findings of testicle biopsy revealed evidence of leprous pathology irrespective of testicular size, semen picture and clinical manifestations. Histopatho-logical changes had shown marked variation and so did not enable categorising them into vascular, interstitial and obliterative phases. These changes were believed to be due to the altered gonadal state in leprosy. The therapeutic efficacy of the indigenous preparations, Speman and Tentex forte (Himalaya) was evaluated subjectively as well as objectively in 34 patients. 823% of cases showed subjective improvement while objective improvement in spermogram was noted in 87.5% cases with oligospermia. The drugs have no side effect and were well tolerated.Sessenta pacientes masculinos de hanseníase (idade média = 27,2 ± 5,04 anos), selecionados aleatoriamente, foram estudados quanto ao envolvimento gonadal e à eficácia terapêutica de duas drogas nativas. Destes pacientes 34 eram casados, com duração média da doença de 4,17± 3,27 anos. Somente os pacientes com hanseníase virchowiana e dimorfa desenvolveram alterações testiculares e de epidídimos. Dor e/ou sensibilidade testicular (virchowianos = 62,5%, dimorfos = 30,0%) foi a sintomatologia mais comum. Função sexual alterada foi observada em 34 (56,6%) casos, enquanto 11 pacientes apresentaram padrão sexual de distribuição pilosa alterado e ginecomastia. O espermograma revelou azoospermia em 19 (35%) dos casos e oligospermia em 16 (26,6%) pacientes. Os achados histopatológicos da biópsia testicular revelaram evidência de lesões específicas não relacionadas ao tamanho do testículo, aos achados do sémen e às manifestações clínicas. As alterações histopatológicas mostraram grande variabilidade, não tendo sido possível classificá-las em vasculares, intersticiais ou obstrutivas: acredita-se que as alterações encontradas sejam devidas ao estado alterado das gônadas na hanseníase. A eficácia das preparações terapêuticas nativas Speman e Tentex forte (Himalaya) foi avaliada de um ponto de vista objetivo e subjetivo em 34 pacientes. Melhora subjetiva foi observada em 82,3% dos casos, enquanto objetivamente o espermograma melhorou em 87,5% dos casos com oligospermia. As drogas não apresentaram efeitos colaterais e foram bem toleradas.Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo1984-11-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAvaliado pelos paresapplication/pdfhttps://periodicos.saude.sp.gov.br/hansenologia/article/view/3557110.47878/hi.1984.v9.35571Hansenologia Internationalis: leprosy and other infectious diseases; Vol. 9 No. 1/2 (1984); 10-20Hansenologia Internationalis: hanseníase e outras doenças infecciosas; v. 9 n. 1/2 (1984); 10-201982-5161reponame:Hansenologia Internationalis (Online)instname:Instituto Lauro de Souza Lima (ILSL)instacron:ILSLenghttps://periodicos.saude.sp.gov.br/hansenologia/article/view/35571/33975MIGAM, PraneshMUKHIJA, Ram D.GUPTA, Arun K.DAYAL, Sat G.GOYAL, Brij M.info:eu-repo/semantics/openAccess2021-06-06T03:39:41Zoai:ojs.periodicos.saude.sp.gov.br:article/35571Revistahttps://periodicos.saude.sp.gov.br/hansenologiaPRIhttps://periodicos.saude.sp.gov.br/hansenologia/oaihansen_int@ilsl.br || hansenologia.internationalis@gmail.com || periodicossp@saude.sp.gov.br1982-51610100-3283opendoar:2021-06-06T03:39:41Hansenologia Internationalis (Online) - Instituto Lauro de Souza Lima (ILSL)false |
dc.title.none.fl_str_mv |
Gonadal involvment in leprosy — study of gynaecomastia, testicular and epididymal involvement and therapeutic efficacy of indigenous drugs |
title |
Gonadal involvment in leprosy — study of gynaecomastia, testicular and epididymal involvement and therapeutic efficacy of indigenous drugs |
spellingShingle |
Gonadal involvment in leprosy — study of gynaecomastia, testicular and epididymal involvement and therapeutic efficacy of indigenous drugs MIGAM, Pranesh Gônadas Ginecomastia Testículo Epidídimos Hanseníase Preparação nativa Gonads Gynaecomastia Testicle, Epididymes Hanseniasis Leprosy Indigenous drugs |
title_short |
Gonadal involvment in leprosy — study of gynaecomastia, testicular and epididymal involvement and therapeutic efficacy of indigenous drugs |
title_full |
Gonadal involvment in leprosy — study of gynaecomastia, testicular and epididymal involvement and therapeutic efficacy of indigenous drugs |
title_fullStr |
Gonadal involvment in leprosy — study of gynaecomastia, testicular and epididymal involvement and therapeutic efficacy of indigenous drugs |
title_full_unstemmed |
Gonadal involvment in leprosy — study of gynaecomastia, testicular and epididymal involvement and therapeutic efficacy of indigenous drugs |
title_sort |
Gonadal involvment in leprosy — study of gynaecomastia, testicular and epididymal involvement and therapeutic efficacy of indigenous drugs |
author |
MIGAM, Pranesh |
author_facet |
MIGAM, Pranesh MUKHIJA, Ram D. GUPTA, Arun K. DAYAL, Sat G. GOYAL, Brij M. |
author_role |
author |
author2 |
MUKHIJA, Ram D. GUPTA, Arun K. DAYAL, Sat G. GOYAL, Brij M. |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
MIGAM, Pranesh MUKHIJA, Ram D. GUPTA, Arun K. DAYAL, Sat G. GOYAL, Brij M. |
dc.subject.por.fl_str_mv |
Gônadas Ginecomastia Testículo Epidídimos Hanseníase Preparação nativa Gonads Gynaecomastia Testicle, Epididymes Hanseniasis Leprosy Indigenous drugs |
topic |
Gônadas Ginecomastia Testículo Epidídimos Hanseníase Preparação nativa Gonads Gynaecomastia Testicle, Epididymes Hanseniasis Leprosy Indigenous drugs |
description |
Sixty male patients of leprosy (mean age = 27.2+5.04 years) selected at random, were studied for gonadal involvement and therapeutic efficacy of two indigenous drugs. Of these 34 were married, with the mean duration of illness 4.17+3.27 years. Only those with lepromatous and dimorphous leprosy developed testicular and epididymal changes. Testicular pain and/or swelling (lepromatous =62.5%, dimorphous 30%) was the commonest presenting feature. Altered sexual function was observed in 34 (56.6%) cases, while 11 patients revealed altered sexual hair pattern and nine gynaeco-mastia. Reduced testicular size associated with soft feel was present in 25% of cases with no testicular sensation in 8 (13.3%) and impaired testicular sensation in 9 (15%) patients. Spermogram revealed azoospermia in 19 (35%) and oligospermia in 16 (26.6%) patients. Histopathological findings of testicle biopsy revealed evidence of leprous pathology irrespective of testicular size, semen picture and clinical manifestations. Histopatho-logical changes had shown marked variation and so did not enable categorising them into vascular, interstitial and obliterative phases. These changes were believed to be due to the altered gonadal state in leprosy. The therapeutic efficacy of the indigenous preparations, Speman and Tentex forte (Himalaya) was evaluated subjectively as well as objectively in 34 patients. 823% of cases showed subjective improvement while objective improvement in spermogram was noted in 87.5% cases with oligospermia. The drugs have no side effect and were well tolerated. |
publishDate |
1984 |
dc.date.none.fl_str_mv |
1984-11-30 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Avaliado pelos pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://periodicos.saude.sp.gov.br/hansenologia/article/view/35571 10.47878/hi.1984.v9.35571 |
url |
https://periodicos.saude.sp.gov.br/hansenologia/article/view/35571 |
identifier_str_mv |
10.47878/hi.1984.v9.35571 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://periodicos.saude.sp.gov.br/hansenologia/article/view/35571/33975 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo |
publisher.none.fl_str_mv |
Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo |
dc.source.none.fl_str_mv |
Hansenologia Internationalis: leprosy and other infectious diseases; Vol. 9 No. 1/2 (1984); 10-20 Hansenologia Internationalis: hanseníase e outras doenças infecciosas; v. 9 n. 1/2 (1984); 10-20 1982-5161 reponame:Hansenologia Internationalis (Online) instname:Instituto Lauro de Souza Lima (ILSL) instacron:ILSL |
instname_str |
Instituto Lauro de Souza Lima (ILSL) |
instacron_str |
ILSL |
institution |
ILSL |
reponame_str |
Hansenologia Internationalis (Online) |
collection |
Hansenologia Internationalis (Online) |
repository.name.fl_str_mv |
Hansenologia Internationalis (Online) - Instituto Lauro de Souza Lima (ILSL) |
repository.mail.fl_str_mv |
hansen_int@ilsl.br || hansenologia.internationalis@gmail.com || periodicossp@saude.sp.gov.br |
_version_ |
1796797579769413632 |